Pendulum Therapeutics developed its product by analyzing the genetic material of microbes in the human body. Its debut product, Pendulum Glucose Control is a medical probiotic, the first of its type to be clinically proven to be effective at lowering blood sugar spikes in people with type 2 diabetes. Classified as a medical food, it bridges the gap between medication that can cause side effects and generic probiotic products that have no scientific backup with regards to efficacy.
Pendulum Glucose Control has been greatly in demand, and so with a $54M investment, manufacturing has scaled up. Other products from Pendulum include supplements for gut health and metabolism optimization supplements, the latter also becoming a key product from the team.
In 2023, Pendulum increased its already thriving publicity with the appointment of actor Halle Berry as its CCO, hinting at a scaling up of its operations in line with its media visibility. Its 2024 breakthrough product has been its GLP-1 Probiotic drink, a first-of-its-kind drink to control metabolism.
Kirsty
Company Specialist at Welcome to the Jungle